Cargando…

N(6)-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression

The mRNA modification N(6)-methyladenosine (m6A) is involved in many post-transcriptional regulatory processes including mRNA stability and translational efficiency. However, it is also imperative to correlate these processes with phenotypic outputs during cancer progression. Here we report that m6A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fry, Nate J., Law, Brittany A., Ilkayeva, Olga R., Carraway, Kristen R., Holley, Christopher L., Mansfield, Kyle D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101291/ https://www.ncbi.nlm.nih.gov/pubmed/30131850 http://dx.doi.org/10.18632/oncotarget.25782

Ejemplares similares

N(6)-methyladenosine is required for the hypoxic stabilization of specific mRNAs
por: Fry, Nate J., et al.
Publicado: (2017)

Hypoxia and Hypoglycemia synergistically regulate mRNA stability
por: Carraway, Kristen R., et al.
Publicado: (2017)

N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection
por: Gokhale, Nandan S., et al.
Publicado: (2016)

N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer
por: Wu, Qunying, et al.
Publicado: (2021)

Hypoxic stabilization of mRNA is HIF-independent but requires mtROS
por: Fortenbery, Grey W, et al.
Publicado: (2018)

Characterization of METTL16 as a cytoplasmic RNA binding protein
por: Nance, Daniel J., et al.
Publicado: (2020)

Research Progress of N6-Methyladenosine in the Cardiovascular System
por: Zheng, Nan, et al.
Publicado: (2020)

Crosstalk between 5-methylcytosine and N(6)-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
por: Tian, Yu, et al.
Publicado: (2023)

N6-methyladenosine links RNA metabolism to cancer progression
por: Dai, Dongjun, et al.
Publicado: (2018)

The potential role of RNA N6-methyladenosine in Cancer progression
por: Wang, Tianyi, et al.
Publicado: (2020)

Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy
por: Li, Hui, et al.
Publicado: (2021)

m6A regulates breast cancer proliferation and migration through stage-dependent changes in Epithelial to Mesenchymal Transition gene expression
por: Dorgham, Mohammed G., et al.
Publicado: (2023)

N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
por: Zheng, Xin, et al.
Publicado: (2023)

Changes of N6-methyladenosine modulators promote breast cancer progression
por: Wu, Lianpin, et al.
Publicado: (2019)

Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders
por: Lei, Chunguang, et al.
Publicado: (2022)

Epitranscriptic regulation of HRAS by N(6)-methyladenosine drives tumor progression
por: Pan, Yongbo, et al.
Publicado: (2023)

Research progress of N6-methyladenosine in colorectal cancer: A review
por: Lin, Yu, et al.
Publicado: (2023)

KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
por: Lan, Tian, et al.
Publicado: (2019)

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson's Disease
por: Quan, Wei, et al.
Publicado: (2021)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies
por: Tan, Fenghua, et al.
Publicado: (2021)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

Single-cell N(6)-methyladenosine regulator patterns guide intercellular communication of tumor microenvironment that contribute to colorectal cancer progression and immunotherapy
por: Gao, Yuzhen, et al.
Publicado: (2022)

attract: A Method for Identifying Core Pathways That Define Cellular Phenotypes
por: Mar, Jessica C., et al.
Publicado: (2011)

An image analysis method for regionally defined cellular phenotyping of the Drosophila midgut
por: Viitanen, Arto, et al.
Publicado: (2021)

A defined N6-methyladenosine (m(6)A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions
por: Gheller, Brandon J., et al.
Publicado: (2020)

Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer’s disease
por: Ni, Pengyun, et al.
Publicado: (2023)

Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma
por: Liu, Jinfang, et al.
Publicado: (2021)

N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer
por: Song, Yanni, et al.
Publicado: (2021)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
por: Wang, Shanshan, et al.
Publicado: (2021)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer
por: Ouyang, Dengjie, et al.
Publicado: (2023)

RNA N6-Methyladenosine-Related Gene Contribute to Clinical Prognostic Impact on Patients With Liver Cancer
por: Wang, Wei, et al.
Publicado: (2020)

N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
por: Li, Jinming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o63k330qlo16ucidd0jfp1m76h